Home > > > > Report Detail

Global and Japan Atropine Market Insights, Forecast to 2027

Publisher Name :
Date: 13-Sep-2021
No. of pages: 147
Inquire Before Buying

Atropine is a medication to treat certain types of nerve agent and pesticide poisonings as well as some types of slow heart rate and to decrease saliva production during surgery. It is typically given intravenously or by injection into a muscle. Eye drops are also available which are used to treat uveitis and early amblyopia. The intravenous solution usually begins working within a minute and lasts half an hour to an hour. Large doses may be required to treat some poisonings. Common side effects include a dry mouth, large pupils, urinary retention, constipation, and a fast heart rate. It should generally not be used in people with angle closure glaucoma. While there is no evidence that its use during pregnancy causes birth defects, it has not been well studied. It is likely safe during breastfeeding. It is an antimuscarinic (a type of anticholinergic) that works by inhibiting the parasympathetic nervous system. Atropine occurs naturally in a number of plants of the nightshade family including deadly nightshade, Jimson weed, and mandrake. It was first isolated in 1833. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. It is available as a generic medication and is not very expensive.

Global Atropine key players include C²PHARMA, RESONANCE LABORATORIES, ROLABO OUTSOURCING, CR Double-Crane, Katsura Chemical, etc. Global top five manufacturers hold a share about 35%. China, Europe and North America is the largest market, each with a share about 25%, followed by Japan, with a share about 15 percent. In terms of product, Injection is the largest segment, with a share about 80%. And in terms of application, the largest application is Gastrointestinal, followed by Ophthalmology, etc.

Market Analysis and Insights: Global and Japan Atropine Market

This report focuses on global and Japan Atropine market.

In 2020, the global Atropine market size was US$ 510 million and it is expected to reach US$ 452 million by the end of 2027, with a CAGR of -1.7% during 2021-2027. In Japan the Atropine market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Atropine Scope and Market Size

Atropine market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Atropine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.

For Japan market, this report focuses on the Atropine market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in Japan.

Segment by Type

- Injection

- Drop

- Gel

Segment by Application

- Gastrointestinal

- Ophthalmology

- Other

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

By Company

- C²PHARMA

- RESONANCE LABORATORIES

- ROLABO OUTSOURCING

- Minsheng

- CR Double-Crane

- HENAN PURUI

- Albany Molecular Research

- Alchem International

- SAURAV CHEMICALS

- Katsura Chemical

- Hangzhou Vega

- Wuhan senwayer century

Global and Japan Atropine Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Atropine Product Introduction
1.2 Market by Type
1.2.1 Global Atropine Market Size Growth Rate by Type
1.2.2 Injection
1.2.3 Drop
1.2.4 Gel
1.3 Market by Application
1.3.1 Global Atropine Market Size Growth Rate by Application
1.3.2 Gastrointestinal
1.3.3 Ophthalmology
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Atropine Market Size, Estimates and Forecasts
2.1.1 Global Atropine Revenue 2016-2027
2.1.2 Global Atropine Sales 2016-2027
2.2 Global Atropine, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Atropine Historical Market Size by Region (2016-2021)
2.3.1 Global Atropine Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Atropine Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Atropine Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Atropine Sales Forecast by Region (2022-2027)
2.4.2 Global Atropine Revenue Forecast by Region (2022-2027)
3 Global Atropine Competitor Landscape by Players
3.1 Global Top Atropine Manufacturers by Sales
3.1.1 Global Atropine Sales by Manufacturer (2016-2021)
3.1.2 Global Atropine Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Atropine Manufacturers by Revenue
3.2.1 Key Atropine Manufacturers Covered: Ranking by Revenue
3.2.2 Global Atropine Revenue by Manufacturers (2016-2021)
3.2.3 Global Atropine Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Atropine Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Atropine Revenue in 2020
3.2.6 Global Atropine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Atropine Price by Manufacturers
3.4 Global Atropine Manufacturing Base Distribution, Product Types
3.4.1 Atropine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Atropine Product Type
3.4.3 Date of International Manufacturers Enter into Atropine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Atropine Market Size by Type (2016-2021)
4.1.1 Global Atropine Sales by Type (2016-2021)
4.1.2 Global Atropine Revenue by Type (2016-2021)
4.1.3 Atropine Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Atropine Market Size Forecast by Type (2022-2027)
4.2.1 Global Atropine Sales Forecast by Type (2022-2027)
4.2.2 Global Atropine Revenue Forecast by Type (2022-2027)
4.2.3 Atropine Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Atropine Market Size by Application (2016-2021)
5.1.1 Global Atropine Sales by Application (2016-2021)
5.1.2 Global Atropine Revenue by Application (2016-2021)
5.1.3 Atropine Price by Application (2016-2021)
5.2 Atropine Market Size Forecast by Application (2022-2027)
5.2.1 Global Atropine Sales Forecast by Application (2022-2027)
5.2.2 Global Atropine Revenue Forecast by Application (2022-2027)
5.2.3 Global Atropine Price Forecast by Application (2022-2027)
6 Japan by Players, Type and Application
6.1 Japan Atropine Market Size YoY Growth 2016-2027
6.1.1 Japan Atropine Sales YoY Growth 2016-2027
6.1.2 Japan Atropine Revenue YoY Growth 2016-2027
6.1.3 Japan Atropine Market Share in Global Market 2016-2027
6.2 Japan Atropine Market Size by Players (International and Local Players)
6.2.1 Japan Top Atropine Players by Sales (2016-2021)
6.2.2 Japan Top Atropine Players by Revenue (2016-2021)
6.3 Japan Atropine Historic Market Review by Type (2016-2021)
6.3.1 Japan Atropine Sales Market Share by Type (2016-2021)
6.3.2 Japan Atropine Revenue Market Share by Type (2016-2021)
6.3.3 Japan Atropine Price by Type (2016-2021)
6.4 Japan Atropine Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan Atropine Sales Forecast by Type (2022-2027)
6.4.2 Japan Atropine Revenue Forecast by Type (2022-2027)
6.4.3 Japan Atropine Price Forecast by Type (2022-2027)
6.5 Japan Atropine Historic Market Review by Application (2016-2021)
6.5.1 Japan Atropine Sales Market Share by Application (2016-2021)
6.5.2 Japan Atropine Revenue Market Share by Application (2016-2021)
6.5.3 Japan Atropine Price by Application (2016-2021)
6.6 Japan Atropine Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan Atropine Sales Forecast by Application (2022-2027)
6.6.2 Japan Atropine Revenue Forecast by Application (2022-2027)
6.6.3 Japan Atropine Price Forecast by Application (2022-2027)
7 North America
7.1 North America Atropine Market Size YoY Growth 2016-2027
7.2 North America Atropine Market Facts & Figures by Country
7.2.1 North America Atropine Sales by Country (2016-2021)
7.2.2 North America Atropine Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Atropine Market Size YoY Growth 2016-2027
8.2 Asia Pacific Atropine Market Facts & Figures by Region
8.2.1 Asia Pacific Atropine Sales by Region (2016-2021)
8.2.2 Asia Pacific Atropine Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Atropine Market Size YoY Growth 2016-2027
9.2 Europe Atropine Market Facts & Figures by Country
9.2.1 Europe Atropine Sales by Country (2016-2021)
9.2.2 Europe Atropine Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Atropine Market Size YoY Growth 2016-2027
10.2 Latin America Atropine Market Facts & Figures by Country
10.2.1 Latin America Atropine Sales by Country (2016-2021)
10.2.2 Latin America Atropine Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Atropine Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Atropine Market Facts & Figures by Country
11.2.1 Middle East and Africa Atropine Sales by Country (2016-2021)
11.2.2 Middle East and Africa Atropine Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 C²PHARMA
12.1.1 C²PHARMA Corporation Information
12.1.2 C²PHARMA Description and Business Overview
12.1.3 C²PHARMA Atropine Sales, Revenue and Gross Margin (2016-2021)
12.1.4 C²PHARMA Atropine Products Offered
12.1.5 C²PHARMA Recent Development
12.2 RESONANCE LABORATORIES
12.2.1 RESONANCE LABORATORIES Corporation Information
12.2.2 RESONANCE LABORATORIES Description and Business Overview
12.2.3 RESONANCE LABORATORIES Atropine Sales, Revenue and Gross Margin (2016-2021)
12.2.4 RESONANCE LABORATORIES Atropine Products Offered
12.2.5 RESONANCE LABORATORIES Recent Development
12.3 ROLABO OUTSOURCING
12.3.1 ROLABO OUTSOURCING Corporation Information
12.3.2 ROLABO OUTSOURCING Description and Business Overview
12.3.3 ROLABO OUTSOURCING Atropine Sales, Revenue and Gross Margin (2016-2021)
12.3.4 ROLABO OUTSOURCING Atropine Products Offered
12.3.5 ROLABO OUTSOURCING Recent Development
12.4 Minsheng
12.4.1 Minsheng Corporation Information
12.4.2 Minsheng Description and Business Overview
12.4.3 Minsheng Atropine Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Minsheng Atropine Products Offered
12.4.5 Minsheng Recent Development
12.5 CR Double-Crane
12.5.1 CR Double-Crane Corporation Information
12.5.2 CR Double-Crane Description and Business Overview
12.5.3 CR Double-Crane Atropine Sales, Revenue and Gross Margin (2016-2021)
12.5.4 CR Double-Crane Atropine Products Offered
12.5.5 CR Double-Crane Recent Development
12.6 HENAN PURUI
12.6.1 HENAN PURUI Corporation Information
12.6.2 HENAN PURUI Description and Business Overview
12.6.3 HENAN PURUI Atropine Sales, Revenue and Gross Margin (2016-2021)
12.6.4 HENAN PURUI Atropine Products Offered
12.6.5 HENAN PURUI Recent Development
12.7 Albany Molecular Research
12.7.1 Albany Molecular Research Corporation Information
12.7.2 Albany Molecular Research Description and Business Overview
12.7.3 Albany Molecular Research Atropine Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Albany Molecular Research Atropine Products Offered
12.7.5 Albany Molecular Research Recent Development
12.8 Alchem International
12.8.1 Alchem International Corporation Information
12.8.2 Alchem International Description and Business Overview
12.8.3 Alchem International Atropine Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Alchem International Atropine Products Offered
12.8.5 Alchem International Recent Development
12.9 SAURAV CHEMICALS
12.9.1 SAURAV CHEMICALS Corporation Information
12.9.2 SAURAV CHEMICALS Description and Business Overview
12.9.3 SAURAV CHEMICALS Atropine Sales, Revenue and Gross Margin (2016-2021)
12.9.4 SAURAV CHEMICALS Atropine Products Offered
12.9.5 SAURAV CHEMICALS Recent Development
12.10 Katsura Chemical
12.10.1 Katsura Chemical Corporation Information
12.10.2 Katsura Chemical Description and Business Overview
12.10.3 Katsura Chemical Atropine Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Katsura Chemical Atropine Products Offered
12.10.5 Katsura Chemical Recent Development
12.11 C²PHARMA
12.11.1 C²PHARMA Corporation Information
12.11.2 C²PHARMA Description and Business Overview
12.11.3 C²PHARMA Atropine Sales, Revenue and Gross Margin (2016-2021)
12.11.4 C²PHARMA Atropine Products Offered
12.11.5 C²PHARMA Recent Development
12.12 Wuhan senwayer century
12.12.1 Wuhan senwayer century Corporation Information
12.12.2 Wuhan senwayer century Description and Business Overview
12.12.3 Wuhan senwayer century Atropine Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Wuhan senwayer century Products Offered
12.12.5 Wuhan senwayer century Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Atropine Industry Trends
13.2 Atropine Market Drivers
13.3 Atropine Market Challenges
13.4 Atropine Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Atropine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Atropine Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Injection
Table 3. Major Manufacturers of Drop
Table 4. Major Manufacturers of Gel
Table 5. Global Atropine Market Size Growth Rate by Application (2021-2027) & (Kg)
Table 6. Global Atropine Market Size by Region (Kg) & (US$ Million), 2016 VS 2021 VS 2027
Table 7. Global Atropine Sales by Regions (2016-2021) & (Kg)
Table 8. Global Atropine Sales Market Share by Regions (2016-2021)
Table 9. Global Atropine Revenue by Regions (2016-2021) & (US$ Million)
Table 10. Global Atropine Sales Forecast by Region (2022-2027) & (Kg)
Table 11. Global Atropine Sales Market Share Forecast by Region (2022-2027)
Table 12. Global Atropine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 13. Global Atropine Revenue Market Share Forecast by Region (2022-2027)
Table 14. Global Atropine Sales by Manufacturers (2016-2021) (Kg)
Table 15. Global Atropine Sales Share by Manufacturers (2016-2021)
Table 16. Ranking of Global Top Atropine Manufacturers by Revenue (US$ Million) in 2020
Table 17. Atropine Revenue by Manufacturers (2016-2021) (US$ Million)
Table 18. Atropine Revenue Share by Manufacturers (2016-2021)
Table 19. Global Atropine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 20. Global Atropine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Atropine as of 2020)
Table 21. Key Manufacturers Atropine Price (2016-2021) (USD/Kg)
Table 22. Atropine Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Atropine Product Type
Table 24. Date of International Manufacturers Enter into Atropine Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Atropine Sales by Type (2016-2021) (Kg)
Table 27. Global Atropine Sales Share by Type (2016-2021)
Table 28. Global Atropine Revenue by Type (2016-2021) (US$ Million)
Table 29. Global Atropine Revenue Share by Type (2016-2021)
Table 30. Atropine Average Selling Price (ASP) by Type (2016-2021) & (USD/Kg)
Table 31. Global Atropine Sales Forecast by Type (2022-2027) & (Kg)
Table 32. Global Atropine Sales Market Share Forecast by Type (2022-2027)
Table 33. Global Atropine Revenue Forecast V (2022-2027) & (US$ Million)
Table 34. Global Atropine Revenue Market Share Forecast by Type (2022-2027)
Table 35. Global Atropine Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Kg)
Table 36. Global Atropine Sales by Application (2016-2021) (Kg)
Table 37. Global Atropine Sales Share by Application (2016-2021)
Table 38. Global Atropine Revenue by Application (2016-2021) (US$ Million)
Table 39. Global Atropine Revenue Share by Application (2016-2021)
Table 40. Atropine Average Selling Price (ASP) by Application (2016-2021) & (USD/Kg)
Table 41. Global Atropine Sales Forecast by Application (2022-2027) & (Kg)
Table 42. Global Atropine Sales Market Share Forecast by Application (2022-2027)
Table 43. Global Atropine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 44. Global Atropine Revenue Market Share Forecast by Application (2022-2027)
Table 45. Global Atropine Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Kg)
Table 46. Japan Atropine Sales (Kg) of Key Companies (2016-2021)
Table 47. Japan Atropine Sales Share by Company (2016-2021)
Table 48. Japan Atropine Revenue (US$ Million) by Company (2016-2021)
Table 49. Japan Atropine Revenue Share by Company (2016-2021)
Table 50. Japan Atropine Sales (Kg) by Type (2016-2021)
Table 51. Japan Atropine Sales Share by Type (2016-2021)
Table 52. Japan Atropine Revenue (US$ Million) Market Share by Type (2016-2021)
Table 53. Japan Atropine Price (USD/Kg) by Type (2016-2021)
Table 54. Japan Atropine Sales (Kg) by Type (2022-2027)
Table 55. Japan Atropine Sales Share by Type (2022-2027)
Table 56. Japan Atropine Revenue (US$ Million) Market Share by Type (2022-2027)
Table 57. Japan Atropine Revenue Share by Type (2022-2027)
Table 58. Japan Atropine Price (USD/Kg) by Type (2022-2027)
Table 59. Japan Atropine Sales (Kg) by Application (2016-2021)
Table 60. Japan Atropine Sales Share by Application (2016-2021)
Table 61. Japan Atropine Revenue (US$ Million) Market Share by Application (2016-2021)
Table 62. Japan Atropine Price (USD/Kg) by Application (2016-2021)
Table 63. Japan Atropine Sales (Kg) by Application (2022-2027)
Table 64. Japan Atropine Sales Share by Application (2022-2027)
Table 65. Japan Atropine Revenue (US$ Million) Market Share by Application (2022-2027)
Table 66. Japan Atropine Revenue Share by Application (2022-2027)
Table 67. Japan Atropine Price (USD/Kg) by Application (2022-2027)
Table 68. North America Atropine Sales by Country (2016-2021) & (Kg)
Table 69. North America Atropine Sales Market Share by Country (2016-2021)
Table 70. North America Atropine Revenue by Country (2016-2021) & (US$ Million)
Table 71. North America Atropine Revenue Market Share by Country (2016-2021)
Table 72. Asia Pacific Atropine Sales by Region (2016-2021) & (Kg)
Table 73. Asia Pacific Atropine Sales Market Share by Region (2016-2021)
Table 74. Asia Pacific Atropine Revenue by Region (2016-2021) & (US$ Million)
Table 75. Asia Pacific Atropine Revenue Market Share by Region (2016-2021)
Table 76. Europe Atropine Sales by Country (2016-2021) & (Kg)
Table 77. Europe Atropine Sales Market Share by Country (2016-2021)
Table 78. Europe Atropine Revenue by Country (2016-2021) & (US$ Million)
Table 79. Europe Atropine Revenue Market Share by Country (2016-2021)
Table 80. Latin America Atropine Sales by Country (2016-2021) & (Kg)
Table 81. Latin America Atropine Sales Market Share by Country (2016-2021)
Table 82. Latin Americaa Atropine Revenue by Country (2016-2021) & (US$ Million)
Table 83. Latin America Atropine Revenue Market Share by Country (2016-2021)
Table 84. Middle East and Africa Atropine Sales by Country (2016-2021) & (Kg)
Table 85. Middle East and Africa Atropine Sales Market Share by Country (2016-2021)
Table 86. Middle East and Africa Atropine Revenue by Country (2016-2021) & (US$ Million)
Table 87. Middle East and Africa Atropine Revenue Market Share by Country (2016-2021)
Table 88. C²PHARMA Corporation Information
Table 89. C²PHARMA Description and Business Overview
Table 90. C²PHARMA Atropine Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 91. C²PHARMA Atropine Product
Table 92. C²PHARMA Recent Development
Table 93. RESONANCE LABORATORIES Corporation Information
Table 94. RESONANCE LABORATORIES Description and Business Overview
Table 95. RESONANCE LABORATORIES Atropine Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 96. RESONANCE LABORATORIES Product
Table 97. RESONANCE LABORATORIES Recent Development
Table 98. ROLABO OUTSOURCING Corporation Information
Table 99. ROLABO OUTSOURCING Description and Business Overview
Table 100. ROLABO OUTSOURCING Atropine Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 101. ROLABO OUTSOURCING Product
Table 102. ROLABO OUTSOURCING Recent Development
Table 103. Minsheng Corporation Information
Table 104. Minsheng Description and Business Overview
Table 105. Minsheng Atropine Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 106. Minsheng Product
Table 107. Minsheng Recent Development
Table 108. CR Double-Crane Corporation Information
Table 109. CR Double-Crane Description and Business Overview
Table 110. CR Double-Crane Atropine Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 111. CR Double-Crane Product
Table 112. CR Double-Crane Recent Development
Table 113. HENAN PURUI Corporation Information
Table 114. HENAN PURUI Description and Business Overview
Table 115. HENAN PURUI Atropine Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 116. HENAN PURUI Product
Table 117. HENAN PURUI Recent Development
Table 118. Albany Molecular Research Corporation Information
Table 119. Albany Molecular Research Description and Business Overview
Table 120. Albany Molecular Research Atropine Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 121. Albany Molecular Research Product
Table 122. Albany Molecular Research Recent Development
Table 123. Alchem International Corporation Information
Table 124. Alchem International Description and Business Overview
Table 125. Alchem International Atropine Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 126. Alchem International Product
Table 127. Alchem International Recent Development
Table 128. SAURAV CHEMICALS Corporation Information
Table 129. SAURAV CHEMICALS Description and Business Overview
Table 130. SAURAV CHEMICALS Atropine Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 131. SAURAV CHEMICALS Product
Table 132. SAURAV CHEMICALS Recent Development
Table 133. Katsura Chemical Corporation Information
Table 134. Katsura Chemical Description and Business Overview
Table 135. Katsura Chemical Atropine Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 136. Katsura Chemical Product
Table 137. Katsura Chemical Recent Development
Table 138. Hangzhou Vega Corporation Information
Table 139. Hangzhou Vega Description and Business Overview
Table 140. Hangzhou Vega Atropine Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 141. Hangzhou Vega Product
Table 142. Hangzhou Vega Recent Development
Table 143. Wuhan senwayer century Corporation Information
Table 144. Wuhan senwayer century Description and Business Overview
Table 145. Wuhan senwayer century Atropine Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 146. Wuhan senwayer century Product
Table 147. Wuhan senwayer century Recent Development
Table 148. Atropine Market Trends
Table 149. Atropine Market Drivers
Table 150. Atropine Market Challenges
Table 151. Atropine Market Restraints
Table 152. Atropine Customers List
Table 153. Atropine Distributors List
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
List of Figures
Figure 1. Atropine Product Picture
Figure 2. Global Atropine Sales Market Share by Type in 2020 & 2027
Figure 3. Injection Product Picture
Figure 4. Drop Product Picture
Figure 5. Gel Product Picture
Figure 6. Global Atropine Sales Market Share by Application in 2020 & 2027
Figure 7. Gastrointestinal
Figure 8. Ophthalmology
Figure 9. Other
Figure 10. Atropine Report Years Considered
Figure 11. Global Atropine Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Atropine Market Size 2016-2027 (US$ Million)
Figure 13. Global Atropine Sales 2016-2027 (Kg)
Figure 14. Global Atropine Market Size Market Share by Region: 2021 Versus 2027
Figure 15. Global Atropine Sales Market Share by Region (2016-2021)
Figure 16. Global Atropine Sales Market Share by Region in 2020
Figure 17. Global Atropine Revenue Market Share by Region (2016-2021)
Figure 18. Global Atropine Revenue Market Share by Region in 2020
Figure 19. Global Atropine Sales Share by Manufacturer in 2020
Figure 20. The Top 10 and 5 Players Market Share by Atropine Revenue in 2020
Figure 21. Atropine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 22. Global Atropine Sales Market Share by Type (2016-2021)
Figure 23. Global Atropine Sales Market Share by Type in 2020
Figure 24. Global Atropine Revenue Market Share by Type (2016-2021)
Figure 25. Global Atropine Revenue Market Share by Type in 2020
Figure 26. Global Atropine Sales Market Share by Application (2016-2021)
Figure 27. Global Atropine Sales Market Share by Application in 2020
Figure 28. Global Atropine Revenue Market Share by Application (2016-2021)
Figure 29. Global Atropine Revenue Market Share by Application in 2020
Figure 30. Japan Atropine Sales Growth Rate 2016-2027 (Kg)
Figure 31. Japan Atropine Revenue Growth Rate 2016-2027 (US$ Million)
Figure 32. Japan Atropine Market Share in Global Market 2016-2027
Figure 33. Japan 5 and 10 Largest Atropine Players Market Share by Revenue in Atropine in 2020
Figure 34. Japan Atropine Revenue Share by Type (2016-2021)
Figure 35. Japan Atropine Revenue Growth Rate by Type in 2016 & 2020
Figure 36. Japan Atropine Revenue Share by Application (2016-2021)
Figure 37. Japan Atropine Revenue Growth Rate by Application in 2016 & 2020
Figure 38. North America Atropine Sales Growth Rate 2016-2021 (Kg)
Figure 39. North America Atropine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 40. North America Atropine Sales Market Share by Country in 2020
Figure 41. North America Atropine Revenue Market Share by Country in 2020
Figure 42. U.S. Atropine Sales Growth Rate (2016-2021) (Kg)
Figure 43. U.S. Atropine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Canada Atropine Sales Growth Rate (2016-2021) (Kg)
Figure 45. Canada Atropine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Europe Atropine Sales Growth Rate 2016-2021 (Kg)
Figure 47. Europe Atropine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 48. Europe Atropine Sales Market Share by Country in 2020
Figure 49. Europe Atropine Revenue Market Share by Country in 2020
Figure 50. Germany Atropine Sales Growth Rate (2016-2021) (Kg)
Figure 51. Germany Atropine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 52. France Atropine Sales Growth Rate (2016-2021) (Kg)
Figure 53. France Atropine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 54. U.K. Atropine Sales Growth Rate (2016-2021) (Kg)
Figure 55. U.K. Atropine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. Italy Atropine Sales Growth Rate (2016-2021) (Kg)
Figure 57. Italy Atropine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. Russia Atropine Sales Growth Rate (2016-2021) (Kg)
Figure 59. Russia Atropine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 60. Asia Pacific Atropine Sales Growth Rate 2016-2021 (Kg)
Figure 61. Asia Pacific Atropine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 62. Asia Pacific Atropine Sales Market Share by Region in 2020
Figure 63. Asia Pacific Atropine Revenue Market Share by Region in 2020
Figure 64. China Atropine Sales Growth Rate (2016-2021) (Kg)
Figure 65. China Atropine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 66. Japan Atropine Sales Growth Rate (2016-2021) (Kg)
Figure 67. Japan Atropine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 68. South Korea Atropine Sales Growth Rate (2016-2021) (Kg)
Figure 69. South Korea Atropine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. India Atropine Sales Growth Rate (2016-2021) (Kg)
Figure 71. India Atropine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. Australia Atropine Sales Growth Rate (2016-2021) (Kg)
Figure 73. Australia Atropine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. Taiwan Atropine Sales Growth Rate (2016-2021) (Kg)
Figure 75. Taiwan Atropine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. Indonesia Atropine Sales Growth Rate (2016-2021) (Kg)
Figure 77. Indonesia Atropine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Thailand Atropine Sales Growth Rate (2016-2021) (Kg)
Figure 79. Thailand Atropine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. Malaysia Atropine Sales Growth Rate (2016-2021) (Kg)
Figure 81. Malaysia Atropine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 82. Philippines Atropine Sales Growth Rate (2016-2021) (Kg)
Figure 83. Philippines Atropine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 84. Vietnam Atropine Sales Growth Rate (2016-2021) (Kg)
Figure 85. Vietnam Atropine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 86. Latin America Atropine Sales Growth Rate 2016-2021 (Kg)
Figure 87. Latin America Atropine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 88. Latin America Atropine Sales Market Share by Country in 2020
Figure 89. Latin America Atropine Revenue Market Share by Country in 2020
Figure 90. Mexico Atropine Sales Growth Rate (2016-2021) (Kg)
Figure 91. Mexico Atropine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 92. Brazil Atropine Sales Growth Rate (2016-2021) (Kg)
Figure 93. Brazil Atropine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 94. Argentina Atropine Sales Growth Rate (2016-2021) (Kg)
Figure 95. Argentina Atropine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 96. Middle East and Africa Atropine Sales Growth Rate 2016-2021 (Kg)
Figure 97. Middle East and Africa Atropine Revenue Growth Rate 2016-2021 (US$ Million)
Figure 98. Middle East and Africa Atropine Sales Market Share by Country in 2020
Figure 99. Middle East and Africa Atropine Revenue Market Share by Country in 2020
Figure 100. Turkey Atropine Sales Growth Rate (2016-2021) (Kg)
Figure 101. Turkey Atropine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 102. Saudi Arabia Atropine Sales Growth Rate (2016-2021) (Kg)
Figure 103. Saudi Arabia Atropine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 104. U.A.E Atropine Sales Growth Rate (2016-2021) (Kg)
Figure 105. U.A.E Atropine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 106. Atropine Value Chain
Figure 107. Channels of Distribution
Figure 108. Distributors Profiles
Figure 109. Bottom-up and Top-down Approaches for This Report
Figure 110. Data Triangulation
Figure 111. Key Executives Interviewed
  • Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87
    The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
  • Global Esomeprazole Magnesium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
  • Global Combination Therapy Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
  • Global Axitinib Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68
    The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
  • Global Lyme Disease Vaccine Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70
    The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......
  • Global Transdermal Absorption Patch Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
  • Global Ketoprofen Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
  • Global Methyl Salicylate Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
  • Global Diclofenac Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs